类他类药物通过在内皮前细胞中对端粒重复结合因子TRF2的上调来增强迁移能力
Ioakim Spyridopoulos1, Judith Haendeler, Carmen Urbich
1Molecular Cardiology, Department of Internal Medicine IV, University of Frankfurt, Frankfurt, Germany.
类他类药物通过增强端粒封闭蛋白TRF2来防止内皮原生细胞衰老,从而保持细胞功能. 这项研究揭示了他类药物对端粒生物学和细胞治疗潜力的新型有益作用.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 内皮原生细胞 (EPC) 在体外培养过程中经历复制性衰老,限制了它们在细胞治疗中的使用.
- 衰老与端粒功能障碍有关,受到线粒钟和文化压力的影响.
- 端粒生物学在以他类药物为媒介的EPC功能增强中的作用需要阐明.
研究的目的:
- 研究端粒生物学在他类药物诱导的内皮细胞 (EPCs) 功能增强中的作用.
- 为了确定他类药物是否可以减轻培养EPCs的过早衰老.
- 探索他类药物影响端粒功能和EPCs的机制.
主要方法:
- 人类EPC被分离和培养.
- 用光在位杂交 (Flow-FISH) 来测量端粒长度.
- 通过免疫栓塞和qRT-PCR评估TRF2 (端粒重复结合因子) 和Chk2 (检查点激酶2) 的表达.
主要成果:
- 活体培养的EPCs没有表现出端粒侵蚀.
- 达丁治疗 (阿托瓦斯塔丁,梅瓦斯塔丁) 增加了TRF2蛋白水平,但没有改变mRNA,这表明后转录调节.
- 类他类药物抑制了Chk2诱导,这是端粒功能障碍的标志物,这种效果取决于TRF2.
结论:
- 活体EPC培养导致由于TRF2损失导致端粒"解开".
- 类药物通过TRF2-依赖的转录后机制来阻止EPC功能衰退.
- 这项研究表明,他类药物对端粒生物学产生了新的有益影响.
更多相关视频
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
相关概念视频
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
